Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P13 SC vs IV in Active Rheumatoid Arthritis
NCT03147248Phase 3Completed
- Sponsor
- Celltrion
- Start
- Sep 2016
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab-dyyb in rheumatoid arthritis (RA), sponsored by Celltrion. Started Sep 2016; status: completed.
02
Drugs
infliximab-dyyb
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03147248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147248.